• Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

  • Nov 27 2024
  • Length: 35 mins
  • Podcast

Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

Listen for free

View show details

  • Summary

  • Brandy Hernandez, PharmD shares nuances on the use of uridine triacetate and glucarpidase in chemotherapy toxicity management

    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE

    Show more Show less
Show more Show less

What listeners say about Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available